S-amlodipine - The 2007 clinical review

Journal of the Indian Medical Association

Volumn 105, Issue 4, 2007, Pages 180-190

  Thacker, Hemant P ^a,b,c,d,e  

^a JASLOK HOSPITAL AND RESEARCH CENTRE   (India)

^b BREACH CANDY HOSPITAL   (India)

^c Bhatia General Hospital   (India)

^d Smt Motiben Dalvi Hospital   (India)

^e Thacker's Clinic   (India)

Author keywords

Enantiomer; Racemic; S amlodipine

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIANGINA PECTORIS AGENT; ANTIHYPERTENSIVE AGENT; ASOMEX; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HISTAMINE H2 RECEPTOR ANTAGONIST; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOSARTAN; NITRATE; PROTON PUMP INHIBITOR; UNCLASSIFIED DRUG; DRUG DERIVATIVE;

ANGINA PECTORIS; ANKLE EDEMA; AREA UNDER THE CURVE; BLOOD PRESSURE REGULATION; CLINICAL TRIAL; COUGHING; DRUG BLOOD LEVEL; DRUG DOSE COMPARISON; DRUG EFFICACY; DRUG HALF LIFE; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; DYSPNEA; ENANTIOMER; FOOT EDEMA; HEADACHE; HUMAN; HYPERTENSION; MALAISE; MYALGIA; PHARMACODYNAMICS; REVIEW; SINGLE DRUG DOSE; TACHYCARDIA; VERTIGO; ARTICLE; CHEMISTRY; CONFORMATION; STEREOISOMERISM;

AMLODIPINE; ANGINA PECTORIS; ANTIHYPERTENSIVE AGENTS; HUMANS; HYPERTENSION; MOLECULAR CONFORMATION; STEREOISOMERISM;

EID: 35248858444     PISSN: 00195847     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (20)

1. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr, et al - The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003; 289: 2560-72.
2. Basile J - The role of existing and newer calcium channel blockers in the treatment of hypertension. J Clin Hypertens 2004; 6: 621-31.
3. Patil PA, Kothekar MA - Development of safer molecules through chirality. Indian J Med Sci 2006; 60: 427-37.
4. Weir MR - Incidence of pedal edema formation with dihydropyridine calcium channel blockers: Issues and practical significance. J Clin Hypertens 2003; 5: 330-5.
5. Goldmann S, Stoltefuss J, Born L - Determination of the absolute configuration of the active amlodipine enantiomer as (-)-S: a correction. J Med Chem 1992; 35: 3341-4.
6. Zhang XP, Loke KE, Mital S, Chahwala S, Hintze TH - Paradoxical release of nitric oxide by an L-type calcium channel antagonist, the R+ enantiomer of amlodipine. J Cardiovasc Pharmacol 2002; 39: 208-14.
7. Cogolludo A, Perez-Vizcaino F, Tamargo J - New insights in the pharmacological therapy of arterial hypertension: Curr Opin Nephrol Hypertens 2005; 14: 423-7.
8. Laufen H, Leitold M - Enantioselective disposition of oral amlodipine in healthy volunteers. Chirality 1994; 6: 531-6.
9. Nayler WG - Pharmacological aspects of calcium antagonism: short term and long term benefits. Drugs 1993; 46: 40-7.
10. Luksa J, Josic D, Kremser M, Kopitar Z, Milutinovic S - Pharmacokinetic behaviour of R-(+)- and S-(-)-amlodipine after single enantiomer administration. J Chromatogr B Biomed Appl 1997; 703: 185-93.
11. Cooper BR, Wightman RM, Jorgenson JW - Quantitation of epinephrine and norepinephrine secretion from individual adrenal medullary cells by microcolumn high-performance liquid chromatography. J Chromatogr B Biomed Appl 1994; 653: 25-34.
12. Park JY, Kim KA, Park PW, Lee OJ, Hyeon Ryu J, Hyeog Lee G, et al - Pharmacokinetic and pharmacodynamic characteristics of a new S-amlodipine formulation in healthy Korean male subjects: a randomized, open-label, two-period, comparative, crossover study. Clin Ther 2006; 28: 1837-47.
13. Pathak L, Hiremath MS, Kerkar PG, Manade VG - Multicentric, clinical trial of S-amlodipine 2.5 mg versus amlodipine 5 mg in the treatment of mild to moderate hypertension - a randomized, double-blind clinical trial. J Assoc Physicians India 2004; 52: 197-202.
14. SESA study - Safety and efficacy of S-amlodipine. JAMA India 2003; 2: 87-92.
15. SESA-II study - Safety and efficacy of S(-) amlodipine in the treatment of hypertension; SESA study group, India. Indian Med Gazette 2005; 139: 529-33.
16. MICRO-SESA-1 study - Safety and efficacy of S (-) amlodipine in the treatment of isolated systolic hypertension; SESA study group, India. Indian Med Gazette 2005; 139: 243-50.
17. MICRO-SESA-II study - Safety and efficacy of S(-) amlodipine in the treatment of hypertension in elderly patients: SESA study group, India. Indian Med Gazette 2005; 139: 353-8.
18. Hiremath JS - The SESA-Angina Study : safety and efficacy of S-amlodipine in angina. Indian Med Gazette 2005; 139: 403-8.
19. Nusar-AM study group - Efficacy and safety of fixed dose combination of S-amlodipine and losartan. Indian Med Gazette 2006; 140: 406-8.
20. SESA-III study - Multicentre clinical evaluation of a fixed-dose combination of S-amlodipine and atenolol in the treatment of mild to moderate hypertension. Indian Med Gazette 2006; 140: 464-6.